Glaukos (GKOS) Cost of Revenue (2014 - 2026)
Glaukos' (GKOS) quarterly Cost of Revenue came in at $34.0 million in Q2 2026, up 26.47% year-over-year from $26.9 million in Q2 2025, and up 2.03% quarter-over-quarter from $33.3 million in Q1 2026.
Analysis
Glaukos (GKOS) Cost of Revenue (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Cost of Revenue for 13 consecutive years, with $34.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 26.47% year-over-year to $34.0 million in Q2 2026; TTM through Jun 2026 was $128.0 million, a 24.92% increase from a year earlier, with the FY2025 full-year figure at $111.8 million, up 18.92% from the prior year.
- Cost of Revenue was $34.0 million for Q2 2026 at Glaukos, up from $33.3 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $34.0 million in Q2 2026 and troughed at $16.9 million in Q3 2022.
- A 5-year average of $23.2 million and a median of $21.4 million in 2024 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue advanced 0.42% in 2022 and surged 51.58% in 2024, its largest moves.
- Over 5 years, Cost of Revenue stood at $17.2 million in 2022, then climbed by 9.69% to $18.9 million in 2023, then soared by 51.58% to $28.6 million in 2024, then advanced by 10.95% to $31.8 million in 2025, then grew by 7.07% to $34.0 million in 2026.
- The last three Cost of Revenue figures came in at $34.0 million (Q2 2026), $33.3 million (Q1 2026), and $31.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Glaukos | 10.68 Bn | 10.57 Bn | 151.59 Mn | 34.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.02 Mn |
| Mar 31, 2026 | 33.34 Mn |
| Dec 31, 2025 | 31.77 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Dec 31, 2024 | 28.64 Mn |
| Sep 30, 2024 | 22.58 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Mar 31, 2024 | 20.26 Mn |
| Dec 31, 2023 | 18.89 Mn |
| Sep 30, 2023 | 18.51 Mn |
| Jun 30, 2023 | 20.10 Mn |
| Mar 31, 2023 | 18.07 Mn |
| Dec 31, 2022 | 17.22 Mn |
| Sep 30, 2022 | 16.86 Mn |
| Jun 30, 2022 | 17.83 Mn |
| Mar 31, 2022 | 17.06 Mn |
| Dec 31, 2021 | 16.87 Mn |
| Sep 30, 2021 | 15.37 Mn |